| Predictors of endoscopic recurrence in resected patients with Crohn’s disease in a long-term follow-up cohort: History of multiple previous resections and residual synchronous disease in the remnant intestine | Yusuf ERZİN,Gürhan ŞİŞMAN,İbrahim HATEMİ,Bilgi BACA,İsmail HAMZAOĞLU,Ahmet DİRİCAN,Uğur KORMAN,Aykut F. ÇELİK | 282–288 |
| Recovery from hemorrhoids and anal fissure without surgery | Abdullah ŞİŞİK,Fatih BAŞAK,Mustafa HASBAHÇECİ,Aylin ACAR,Ali KILIÇ,Yahya ÖZEL,Gürhan BAŞ | 289–294 |
| Probiotics and dietary intervention modulate the colonic mucosa-associated microbiota in high-fat diet populations | Leimin QİAN,Jianming HUANG,Huanlong QİN | 295–304 |
| Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience | Bilgehan AYGEN,Neşe DEMİRTÜRK,Orhan YILDIZ,Mustafa Kemal ÇELEN,İhami ÇELİK,Şener BARUT,Onur URAL,Ayşe BATIREL,Reşit MISTIK,Funda ŞİMŞEK,Ali ASAN,GÜLDEN ERSÖZ,Nesrin TÜRKER,Hüseyin BİLGİN,Sami KIRIKLI,FARUK KARAKEÇİLİ,Gökmen ZARARSIZ,The Study Group for Viral Hepatitis of the Turkish Society of Clini | 305–317 |
| Endoscopic retrograde cholangiography via a permanent access loop | Mustafa KAPLAN,Selçuk DİŞİBEYAZ,Selçuk DİŞİBEYAZ,Erkan PARLAK,Erkin ÖZTAŞ,Volkan GÖKBULUT | 318–323 |
| Validity and reliability analysis of the Turkish version of pediatric nutritional risk score scale | Onur TAŞCI,Özlem BEKEM SOYLU,Ezgi Kiran TAŞCI,Erhan ESER,Betül ORUÇOĞLU,İlker GÜNAY | 324–330 |
| Esmolol inhibits inflammation and apoptosis in the intestinal tissue via the overexpression of NF-κB-p65 in the early stage sepsis rats | Chang-An GUO,Li MA,Xiao-Lu SU,Ying-Zhen WANG,Ling-Ling ZHEN,Bel ZHANG,Hong AN,Hong-Bin LİU | 331–341 |
| Puborectalis muscle and External Anal Sphincter: a functional unit? | Nikolaos ANDROMANAKOS,Dimitrios FILIPPOU,Nikolaos KARANDREAS,Alkiviadis KOSTAKİS | 342–343 |
| Hepatitis B virus reactivation during direct-acting antiviral agent-based therapy for chronic Hepatitis C | Ertuğrul GÜÇLÜ,Sevgi ALAN,Oğuz KARABAY | 344–345 |
|